Aim-traded Venture Life (VLG:92p), a developer, manufacturer and distributor of products for the self-care market, has released another bullish trading update ahead of next month’s interim results. The company also announced this morning that its leading mouthwash, Dentyl, will be involved in a UK clinical trial in partnership with Cardiff University to investigate the use of over-the-counter mouthwashes. The aim is to help reduce the viral load and transmission of COVID-19 in the mouth. A previous review concluded that Cethylpyridinium Chloride, the main ingredient in Venture Life's mouthwash, may be effective in this respect.
Join our community of smart investors
Subscribe today and enjoy unlimited access:
- Comprehensive companies coverage
- Actionable commentary, ideas and portfolios
- Tools and data to help you manage and track investments.
- Help managing your portfolio